Effectiveness of Exercise and Patient-centred Education on Fibromyalgia

Is a Combined Programme of Exercise and Patient-centred Education More Effective Than Exercise Alone in Individuals With Fibromyalgia? A Randomised Controlled Trial

This study aims to compare the effects of an eight-week exercise and patient-centred education programme with eight-week exercise alone programme on disability, pain intensity, health-related quality of life and patient global impression of change.

A prospective, parallel, double-blinded and multi-centre randomised controlled trial will be carried out.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosis of fibromyalgia according to the American College of Rheumatology criteria (2016)

Exclusion Criteria:

  • Presence of uncontrolled medical disorders (cardiovascular/ metabolic/ neurological/ renal)
  • Presence of active oncological disease (or until 5 years and undergoing treatment)
  • Presence of inflammatory rheumatic diseases other than fibromyalgia
  • Presence of inflammatory osteoarticular disease or severe osteoarthritis (grade IV de Kellgren - Lawrence Classification of Osteoarthritis)
  • Previous orthopaedic (column or lower limb) or cardiothoracic surgery in the year before;
  • Disability not compatible with the exercise practice required
  • Pregnancy
  • Attendance to a physiotherapy programme including exercise in the previous three months
  • Difficulty in written communication that prevent the fulfilment of self-reported questionnaires.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Exercise and Patient-centred education

An eight-week programme based on 24 sessions of exercise supervised by a physiotherapist. Exercise will be carried out three times a week. Once a week the exercise session is performed autonomously by patient at home (according to the physiotherapist's recommendations).

Patient-centred Education will follow the principles of transformative learning & incorporate patients' narratives. It will precede 9 of the 24 exercise sessions and be delivered by the same physiotherapist

ACTIVE_COMPARATOR: Exercise
An eight-week programme based on 24 sessions of exercise supervised by a physiotherapist. Exercise will be carried out three times a week. Once a week the exercise session is performed autonomously by patient at home (according to the physiotherapist's recommendations).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain intensity
Time Frame: Baseline
Measured using the Numeric Pain Rating Scale, NPS, 0-10
Baseline
Pain intensity
Time Frame: 4 weeks
Measured using the Numeric Pain Rating Scale, NPS, 0-10
4 weeks
Pain intensity
Time Frame: 8 weeks
Measured using the Numeric Pain Rating Scale, NPS, 0-10
8 weeks
Pain intensity
Time Frame: Follow-up 3 months
Measured using the Numeric Pain Rating Scale, NPS, 0-10
Follow-up 3 months
Disability and Impact of Fibromyalgia
Time Frame: Baseline
Measured using the Revised Fibromyalgia Impact Questionnaire, FIQr, 0-100
Baseline
Disability and Impact of Fibromyalgia
Time Frame: 4 weeks
Measured using the Revised Fibromyalgia Impact Questionnaire, FIQr, 0-100
4 weeks
Disability and Impact of Fibromyalgia
Time Frame: 8 weeks
Measured using the Revised Fibromyalgia Impact Questionnaire, FIQr, 0-100
8 weeks
Disability and Impact of Fibromyalgia
Time Frame: Follow-up 3 months
Measured using the Revised Fibromyalgia Impact Questionnaire, FIQr, 0-100
Follow-up 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neuropathic components in pain
Time Frame: Baseline
Measured using the painDETECT Questionnaire
Baseline
Health-related Quality of Life
Time Frame: Baseline
Measured using the EuroQol 5D 3L, EQ 5D-3L
Baseline
Health-related Quality of Life
Time Frame: 4 weeks
Measured using the EuroQol 5D 3L, EQ 5D-3L
4 weeks
Health-related Quality of Life
Time Frame: 8 weeks
Measured using the EuroQol 5D 3L, EQ 5D-3L
8 weeks
Health-related Quality of Life
Time Frame: Follow-up 3 months
Measured using the EuroQol 5D 3L, EQ 5D-3L
Follow-up 3 months
Patients' perception of improvement or decline in clinical status
Time Frame: 4 weeks
Measured using the The Patient Global Impression of Change Scale, PGIC, 1-7
4 weeks
Patients' perception of improvement or decline in clinical status
Time Frame: 8 weeks
Measured using the Patient Global Impression of Change Scale, PGIC, 1-7
8 weeks
Patients' perception of improvement or decline in clinical status
Time Frame: Follow-up 3 months
Measured using the Patient Global Impression of Change Scale, PGIC, 1-7
Follow-up 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 7, 2020

Primary Completion (ANTICIPATED)

October 1, 2020

Study Completion (ANTICIPATED)

October 1, 2020

Study Registration Dates

First Submitted

January 5, 2020

First Submitted That Met QC Criteria

January 6, 2020

First Posted (ACTUAL)

January 7, 2020

Study Record Updates

Last Update Posted (ACTUAL)

March 10, 2020

Last Update Submitted That Met QC Criteria

March 6, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fibromyalgia

Clinical Trials on Experimental: Exercise and Patient-centred education

3
Subscribe